Detail page

Knowledge Web

Person

Elke Pfaff (1985-)

Name	Elke Pfaff
Time	1985- (Date of birth and death)
Place	Tübingen (Geburtsort) Deutschland
Gender	weiblich
Academic degree	Dr. (an der Medizinischen Fakultät der Universität Heidelberg) (2012)
Variant	Elke Katrin Pfaff
Record type	Person
GND-Identifier	1037262174
Record ID	1037262174
Involved in show all Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma Author Correction: The landscape of genomic alterations across childhood cancers The landscape of genomic alterations across childhood cancers New brain tumor entities emerge from molecular classification of CNS-PNETs Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study Dissecting the genomic complexity underlying medulloblastoma Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Elke Pfaff (1985-)

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma

Author Correction: The landscape of genomic alterations across childhood cancers

The landscape of genomic alterations across childhood cancers

New brain tumor entities emerge from molecular classification of CNS-PNETs

Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study

Dissecting the genomic complexity underlying medulloblastoma

Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma